Trial intelligence / Profile preview

Cranberry vs Nitrofurantoin for UTI Prevention Post-Surgery

NCT03522961Active, not recruiting

Sponsor
Brigham and Women's Hospital
Start
Aug 2018
Primary completion
Sep 2023
Countries
1
01

Overview

Randomised, double-blind trial (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Treatment for clinically suspected or culture-proven UTI at 28 days. Started Aug 2018; status: active, not recruiting.

Beyond the preview

Go deeper on NCT03522961.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03522961.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call